A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa
NCT01000740
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
GENETIC:
EGFR Mutation Test
GENETIC:
Ki-67 protein expression
Sponsor
AstraZeneca